FEROX STRATEGIES for VIATRIS INC
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
Policy and oversight related to the generic pharmaceutical industry H.R.2212/S. 974 - CREATES Act of 2017 H.R. 7251/S.3738 - Hatch-Waxman Integrity Act of 2018 H.R.6294 - REVAMP Act
Foreign entity interest: As the parent entities of Mylan Inc., Mylan NV and Mylan Holdings Limited have a general interest in the issues above.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LUCIA ALONZO | — |
| CRISTINA ANTELO | — |
Trade (domestic/foreign) TRD
Issues related to intellectual property in the North American Free Trade Agreement
Foreign entity interest: As the parent entities of Mylan Inc., Mylan NV and Mylan Holdings Limited have a general interest in the issues above.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LUCIA ALONZO | — |
| CRISTINA ANTELO | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.